Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Overview of glucagon-like peptide-1 and its role in glucose metabolism New-generation antidiabetic agents, particularly those targeting the glucagon-like peptide-1 (GLP-1) pathway, represent a significant advancement in the treatment of type 2 diabetes
Each pathway reflects different clinical considerations related to dosing precision, accessibility, and treatment continuity
2025, doi: 10.1002/edm2.70113
Aufmkolk M, Ingbar JC, Kubota K, Amir SM, Ingbar SH
US$ 28.95
US$ 29.89
US$ 22.38
US$ 25.39
US$ 21.45
